[Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex). Results of a French multicenter clinical trial]
| Autor: | M F, Gagnadoux, C, Loirat, J P, Berthélémé, A, Maisin, A, Kamoun, D, Dabout, D, Poisson, M, Broyer |
|---|---|
| Jazyk: | francouzština |
| Rok vydání: | 1994 |
| Předmět: |
Male
Adolescent Dose-Response Relationship Drug Body Weight Appetite Infant Anemia Recombinant Proteins Hemoglobins Treatment Outcome Renal Dialysis Child Preschool Hypertension Humans Immunologic Factors Kidney Failure Chronic Blood Transfusion Female France Child Cognition Disorders Erythropoietin Growth Disorders |
| Zdroj: | Nephrologie. 15(3) |
| ISSN: | 0250-4960 |
| Popis: | Intravenous recombinant human erythropoietin (Eprex Cilag) was used in 28 hemodialyzed children, treated in 3 French paediatric centers, from November 1989 to November 1990. Transfusion dependency disappeared in all cases: the number of transfusions decreased from 7.3 unit/patient/year to 0.6 unit/pt/year. The mean haemoglobin concentration for the whole group increased from 6.6 +/- 0.8 g/dl, to 9.2 +/- 1.2 at 6 months and 9.7 +/- 0.7 g/dl at 1 year. Twenty-two out of 28 children reached the target haemoglobin value of 9.6 g/dl (6 mmol/dL) within a mean time of 16.5 weeks. Poor responses were due to either a premature withdrawal of treatment because of renal transplantation, or too low a dosage for the age. The study showed indeed that the dose requirement was significantly dependent on physical development: the mean dosage required to maintain haemoglobin concentration at the target value was 300 U/kg/week in children weighing less than 20 kg, 222 U/kg/week in 20-30 kg children, and 135 U/kg/week in those weighing more than 30 kg (p = 0.02). The only complication was an increase in blood pressure, observed in 43% of cases. The increase of anti-hypertensive medication was always successful in controlling blood pressure, and hospitalization was required in only one case. The improvement in general condition was obvious, and in several cases, the cognitive abilities seemed to improve. The growth deficit remained unchanged. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|